We define ourselves by four values

Patient first

Everything we do is aimed at improving patient wellbeing by developing solutions that make personalized medicine more readily available.

Bioinformatic excellence

We believe in the power of R&D and invest our resources in building bioinformatic tools that provide more medically actionable information.

Success is built together

We must collaborate to develop complex genomic solutions needed to enable personalized medicine.

Fun works better

We like to work hard and have figured out that our team does its best work when everyone is motivated and having fun.

The mission

The mission we have set ourselves is to build an ecosystem that combines experts from SeqOne, the industry and academia, in order to deliver the most effective, easy-to-use genomic analysis solutions by following these three principles:

  1. Single minded focus on ease of use in a clinical environment.
  2. Integration of top of the range open-source technologies.
  3. Constant innovation to develop new solutions based on collaboration.

The results of our efforts: a powerful yet easy-to-use constitutional and somatic genomic analysis solution, that is fast becoming used by professionals in both the public and private sectors. The platform streamlines all areas of genomic analysis process, thus helping to make personalized medicine more readily available.

About personalized medicine and genomics

Healthcare is undergoing a revolution known as personalized medicine, that uses the patient’s genomic information to optimize treatment. Using the results of genomic analysis, clinicians can more efficiently diagnose patients and in many cases personalize the treatment to precisely address each patient’s unique needs.

Personalized medicine powered by genomics, has the potential to transform the healthcare industry and deliver significant patient benefits. For this reason, we are committed to making this life changing technology available to as many people as possible.

SeqOne Genomics, the company

SeqOne Genomics is a startup based in Montpellier in the South of France, founded in 2017. The company develops state-of-the-art genomics analysis tools for clinical applications in the fields of cancer and rare diseases. Its flagship product, SeqOne | Platform is a cloud-based end-to-end solution that dramatically reduces the turnaround time and cost required to deliver accurate genetic analyses, for use in mainstream medicine

In the short time since it has launched its platform, the company has secured a user base in a wide range of healthcare establishments including hospitals and private sector testing laboratories. It has won numerous awards including the prestigious i-Lab award and the ARC Cancer Foundation’s Hélène Stark prize. SeqOne is supported by the SATT AxLR and the Montpellier BIC incubator. The company’s investors include Elaia Partners, IRDI SORIDEC and the BPI with additional financial support from Credit Agricole and Caisse d’Epargne Languedoc Roussion.

We believe in a shared vision of genomic medicine for all and the power of teamwork and collaboration to materialize this vision. We have therefore assembled a young and multidisciplinary team.

They trust us

  • It’s very nice to work with SeqOne, I’d never go back to the way I was working before. I have more confidence in the accuracy of my diagnoses and can deliver them much faster.

    Anne-Sophie Lebre

    CHU Reims, France

  • SeqOne is always available to listen and help solve my issues, collaborating with us to deliver practical solutions. This makes SeqOne, in my experience, the best bioinformatic solution on the market.

    Jean-Marc Rey

    CHU Montpellier, France

Our executive team

  • Martin Dubuc - CEO

    A seasoned healthcare executive with global experience who most recently headed up Biogen’s Global Digital Health division, driving personalized and digital medicine. He brings over two decades of experience in the healthcare industry at Pfizer, Merck&Co, Biogen, and thought leadership in digital health.

  • Nicolas Philippe - President - Chief Product & Scientific Officer

    A passionate entrepreneur with a background in mathematics and bioinformatic research, Nicolas’ vision is to make personalized medicine more accessible through better genomic analysis.

  • Guillaume Buwalda - CTO

    Specialized in secure, high performance computer systems, Guillaume has designed SeqOne's platform with performance, security and scalability in mind.


  • Jean-Marc Holder - CSIO

    An international technology executive, Jean-Marc has worked for hi-tech innovators such as Apple, Palm as well as numerous startups and is responsible for strategy, business development and marketing.

  • Danaë Geraud - CFO

    Passionate about entrepreneurship and keen to make an impact, Danae has been working with fast-growing companies for over ten years.  She is responsible for SeqOne's finance, human resources and non-technical operations.

Gender equality

Ensuring gender equality in the workplace is crucial for SeqOne, as we value diversity and inclusivity.

Creating a workplace where all employees, regardless of gender, have equal opportunities to grow professionally and contribute to the company’s success can have numerous benefits.

You can find here our official gender equality score.

SeqOne score
Men/Women income difference40 / 40
Individual income difference35 / 35
% employees who had a raise after returning from maternity leave15 / 15
Number of employees of the under-represented sex among the 10 highest wages5 / 10

Need help improving your genomic analysis process ?
We’d love to help !